Stock Updates

Today’s Top Gainers in the Market Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) from Healthcare

Today’s top gainers include the company Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) which is in the industry Biotechnology, gaining 0.68% today. In the last week its performance is 0.18%, and -20.93% for the past quarter. Currently, Alexion Pharmaceuticals, Inc., ALXN has a target price of 179.72, so today’s gain of 0.68% is a significant step towards its target price. The GAP today is therefore -0.07%.

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), has a market cap of 28517.6, and is based in USA. Insider ownership is at 0.60%, and institutional ownership is 98.80%.

At the current price of 126.65, it has a dividend yield of *TBA, and its target price is 179.72. This is with a profit margin of 5.40%, and total debt/equity of 0.4. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has a P/E of 175.21, as well as a forward P/E of 19.31.

With a current EPS of 0.72, and a forecasted EPS growth for next year at 29.13%,Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has had a EPS growth for the past five years at 5.10%. For the next five years EPS growth is projected to be 19.20%.

Performance for the year is -39.47%. Since its IPO date on 2/28/1996, the total performance to date is -34.05%.

Volume today for Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), is 768508, while its average volume is 1947.37. Whilst the total gain today was 0.68%, it did have a day high of -19.34%.

Volatility for this week has been at 2.41%, and 2.86% for the month. The 52-week low for Alexion Pharmaceuticals, Inc., ALXN has been 14.55%, while the 52-week-high has reached -39.37%.

Looking at its return of investments, which is 1.60%, and its return on assets is 1.10%. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has an operating margin of 22.10%. With a sales growth of 16.80% quarter over quarter. Bearing in mind that Alexion Pharmaceuticals, Inc., ALXN is in the sector Healthcare, its long-term debt/equity is 0.4, and has a current ratio of 3.5 and 3 for quick ratio.

So what is the value of Alexion Pharmaceuticals, Inc.? Well its PEG is 9.12, and the P/S is 10.54, along with a P/B of 3.51. Meanwhile it has a p/cash of 27.75.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Mark Hines

Leave a Comment